Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Versus Regular Dosage For Peritoneal Dialysis In Non-Hypercatabolic Acute Kidney Injury, A Multicenter Randomized Controlled Trial

NCT03438877 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03438877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Versus Regular Dosage For Peritoneal Dialysis In Non-Hypercatabolic Acute Kidney Injury, A Multicenter Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 29, 2018
Completion date
December 26, 2019
Enrollment
6 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, peritoneal dialysis